The 5-hydroxytryptamine (5-HT, also known as serotonin) subtype 6 receptor (5-HT 6 R, also known as HTR6) plays roles in cognition, anxiety and learning and memory disorders, yet new details concerning its regulation remain poorly understood. In this study, we found that 5-HT 6 R directly interacted with SNX14 and that this interaction dramatically increased internalization and degradation of 5-HT 6 R. Knockdown of endogenous SNX14 had the opposite effect. SNX14 is highly expressed in the brain and contains a putative regulator of G-protein signaling (RGS) domain. Although its RGS domain was found to be non-functional as a GTPase activator for Gas, we found that it specifically bound to and sequestered Gas, thus inhibiting downstream cAMP production. We further found that protein kinase A (PKA)-mediated phosphorylation of SNX14 inhibited its binding to Gas and diverted SNX14 from Gas binding to 5-HT 6 R binding, thus facilitating the endocytic degradation of the receptor. Therefore, our results suggest that SNX14 is a dual endogenous negative regulator in 5-HT 6 R-mediated signaling pathway, modulating both signaling and trafficking of 5-HT 6 R.
INTRODUCTION
G-protein-coupled receptors (GPCRs) are seven-transmembrane domain proteins that serve to transduce the intracellular effects of a large variety of hormones or neurotransmitters subserving an equally extensive list of physiological responses (Hill, 2006) . Most GPCRs couple to heterotrimeric G proteins comprised of a, b and c subunits at the plasma membrane. In humans, there are over 20 Ga proteins encoded by 16 genes, which are subdivided into four subfamilies based on sequence identity and shared effector systems (Milligan and Kostenis, 2006) . The duration of G protein signaling is controlled by the lifetime of the Ga subunit in its GTP-bound state. Although Ga subunits have intrinsic GTPase activity, auto-hydrolysis of GTP is often too slow to account for the dynamic switching of GPCR signaling (De Vries et al., 2000; Neubig and Siderovski, 2002) . Proteins containing a regulator of G-protein signaling (RGS) domain bind activated Ga subunits and act as GTP-activating proteins (GAPs), accelerating GTP hydrolysis (De Vries et al., 2000) . So far, RGS proteins for Ga i , Ga q and Ga 12/13 have been well-characterized, but little is known about proteins that might regulate Gas. Previously, SNX13 has identified been as a RGS for Gas that is highly expressed in heart and skeletal muscle and has a role in EGFR degradation (Zheng et al., 2001) .
The role of 5-hydroxytryptamine (5-HT, also known as serotonin) in cognitive processing and performance has been known for many years (Dawson, 2011) . Among various 5-HT receptors, the 5-HT subtype 6 receptor (5-HT 6 R, also known as HTR6) is one of the most recently discovered of the serotonin receptors. It is positively coupled to adenylyl cyclase and increases cAMP production upon activation. It is located almost exclusively within the central nervous system (CNS), including the striatum, olfactory tubercle, nucleus accumbens, hippocampus, cortex, cerebellum, hypothalamus and amygdala (Monsma et al., 1993; Ruat et al., 1993; Ward et al., 1995) . 5-HT 6 R is known to modulate the transmission of several neurotransmitters including acetylcholine, glutamate, dopamine, c-aminobutyric acid, epinephrine and norepinephrine (Dawson, 2011; Mitchell and Neumaier, 2005) . It is involved in various higher brain functions such as memory and cognition (Marcos et al., 2008; Mitchell et al., 2007) as well as in pathophysiological conditions such as anxiety, depression and obsessive compulsive disorder (OCD) (Svenningsson et al., 2007 ), Alzheimer's disease (Geldenhuys and Van der Schyf, 2008) , drug addiction (Lecca et al., 2004) and schizophrenia (Masellis et al., 2001) . Recent evidence also suggests it has a role in obesity (Heal et al., 2011) . Over the past decade, 5-HT 6 R has gained increasing attention and its antagonism has become a promising target for the treatment of various neuropsychological diseases. Nevertheless, very little is known about its regulation and function in the brain.
SNX14 is a member of the sorting nexin family, predicted to have for roles in protein sorting and vesicular trafficking (Carlton et al., 2005) . It contains a putative RGS domain and a phox homology (PX) domain, an N-terminal hydrophobic region and a PX-associated (PXA) domain (Worby and Dixon, 2002) . SNX14 has been isolated from mouse embryonic stem cell (ESC)-derived neurons and was found to be expressed at high levels in the nervous system (Carroll et al., 2001) . A recent study has found that SNX14 protein levels are progressively increased during neuronal development, whereas its knockdown severely impairs both excitatory and inhibitory synaptic transmission (Huang et al., 2014) . Another study has found that SNX14 mutations cause a distinctive autosomal-recessive cerebellar ataxia and intellectual disability syndrome (Thomas et al., 2014) . Therefore, these results suggest that there is an essential role for SNX14 in neuronal development and function, but the underlying mechanism(s) for this remain poorly understood.
Here, we provide evidence that SNX14 is highly expressed in the brain, and as a sorting nexin, it interacts with 5-HT 6 R and accelerates internalization and degradation of 5-HT 6 R. Knockdown of endogenous SNX14 prolonged the cell surface expression of 5-HT 6 R. Although we found that the SNX14 RGS domain does not retain GAP activity for Gas, it specifically bound to and sequestered Gas, thus inhibiting the 5-HT 6 R-mediated signaling pathway. We further reveal that the binding affinity of SNX14 for Gas was almost abolished by phosphorylation of RGS domain by protein kinase A (PKA) and that phosphorylation of SNX14 is also required for the endocytic degradation of 5-HT 6 R. Taken together, our results suggest that SNX14 is a dual negative regulator in 5-HT 6 Rmediated signaling pathways that acts by both sequestering Gas and inducing endocytosis of 5-HT 6 R. RESULTS SNX14 associates with 5-HT 6 R SNX14 consists of a putative RGS domain, a PX domain, an Nterminal hydrophobic region and a PXA domain ( Fig. 1A ; supplementary material Fig. S1A ). In situ hybridization showed that SNX14 was highly expressed in the hippocampus, nucleus accumbens and cerebellum (Fig. 1B) , where 5-HT 6 R is also abundantly expressed. Immunoblotting also showed that SNX14 was also highly expressed in lung, testis and brain regions, such as the hippocampus, cerebellum and cerebral cortex, but that virtually no expression was observed in heart and muscle where SNX13 is known to be abundant (Zheng et al., 2001) , suggesting a mutually exclusive tissue distribution (Fig. 1C) . High levels of SNX14 expression were also detected in primary hippocampal neurons, glial cells and in the HT-22 hippocampal cell line but not in HEK293T, HeLa or COS-7 cells ( Fig. 1D ; supplementary material Fig. S1B ).
Previous studies have shown that SNX3 regulates endosomal trafficking through its PX-domain-mediated interaction with PtdIns(3)P (Xu et al., 2001) . Examination of the phosphoinositidebinding behavior of SNX14 showed that the PX domain bound both PtdIns(3)P and PtdIns(5)P, whereas the PXA domain bound PtdIns(3,4)P 2 , PtdIns(3,4,5)P 3 and PtdIns(4,5)P 2 . Full-length SNX14 displayed a combination of the lipid binding patterns of the PX and PXA domains. Accordingly, the heterogeneously expressed SNX14 domain mutants localize in endosome-like structures in the cytosol or at the plasma membrane, suggesting that SNX14 might play a role in membrane trafficking (supplementary material Fig. S1C,D) .
5-HT 6 R is a Gas-linked serotonin receptor and SNX14 contains a putative RGS domain. The closely related protein SNX13 has been reported to act as an RGS for Gas. Given that the expression profiles in the CNS are similar for SNX14 and 5-HT 6 R, we wondered whether SNX14 interacts with 5-HT 6 R. The third intracellular loop (iL3) has a fairly long stretch of amino acids and a previous study has shown that iL3 of 5-HT 6 R interacts with Gas (Kang et al., 2005) . Micro-liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis using immunoprecipitated brain lysates with GST-conjugated iL3 of 5-HT 6 R showed that besides various endocytic proteins, such as dynamin, AP-2, amphiphysin and epsin, SNX14 was also identified as one of its endogenous binding partners (Fig. 1E) .
When heterogeneously expressed in COS-7 cells, 5-HT 6 R interacted with the full-length SNX14 and RGS-PX domain of SNX14 but not with SNX9 and SNX18 (Fig. 1F) . We determined that the interaction between 5-HT 6 R and SNX14 was mediated by the iL3 of 5-HT 6 R and the RGS domain of SNX14 (Fig. 1G) . The K262 and K265 residues of iL3 appear to be the binding sites for SNX14 because a K262A and K265A double mutant showed little interaction with SNX14 (Fig. 1H) . The RGS of SNX14 did not interact with b 2 adrenergic receptor (b 2 AR, also known as ADRB2) or dopamine D 1 receptor (D 1 DR, also known as DRD1), which are related Gas-linked GPCRs (Fig. 1I ).
SNX14 accelerates internalization and degradation of the 5-HT 6 R Next, we tested whether the interaction between SNX14 and 5-HT 6 R plays a role in endocytic trafficking of 5-HT 6 R. The RGS-PX domain of SNX14 was coexpressed with 5-HT 6 R in HEK293T cells and cells were treated with 5-HT to induce internalization of 5-HT 6 R. Curiously, the expression of the RGS-PX domain decreased total and surface 5-HT 6 R to the same extent seen in control cells after 30 min exposure to 5-HT. Treatment of these cells with 5-HT evoked no further decrement of total or surface 5-HT 6 R ( Fig. 2A-D ). This endocytic degradation by the RGS-PX domain was not detected for b 2 AR (Fig. 2B-D) .
These results suggest that SNX14 dramatically increases the rate of constitutive endocytosis and degradation of 5-HT 6 R. This is confirmed by experiments using Tet-On inducible expression of the RGS-PX domain in cells transiently or stably expressing 5-HT 6 R (Fig. 2E) . Using liposome-mediated delivery of purified the RGS-PX domain of SNX14, we show that 5-HT 6 R gradually decreased from the cell surface after delivery of purified the RGS-PX domain (Fig. 2F) . We found that not only the RGS-PX domain but also full-length SNX14 had a similar effect and further found that phosphoinositide-binding property of the PX domain is required given that the DPX mutant of SNX14 failed to induce 5-HT 6 R internalization ( Fig. 3A-E) . Endogenous SNX14 was recruited to the plasma membrane by 5-HT treatment in HT-22 cells (supplementary material Fig. S2A ). Total internal reflection fluorescence (TIRF) imaging also demonstrated that full-length SNX14 was recruited to the plasma membrane by 5-HT treatment and that some of SNX14 spots were re-internalized ( Fig. 3F-J) .
Knockdown of SNX14 expression prolongs the expression of 5-HT 6 R We next investigated whether knockdown of SNX14 alters the expression of 5-HT 6 R in HT-22 cells that endogenously express high levels of SNX14 and 5-HT 6 R. Three independent short hairpin RNA (shRNA) constructs targeting SNX14 were made ( Fig. 4A) and suppression of SNX14 expression by shRNA1 and shRNA2 in HT-22 cells was confirmed, whereas shRNA3 had no effect (Fig. 4B) . When endogenous expression of SNX14 was suppressed by shRNA1, shRNA2 or shRNA1+2, the levels of 5-HT 6 R were significantly higher than those in the control or shRNA3-transfected cells (Fig. 4B) . Furthermore, 5-HT exposure did not further downregulate 5-HT 6 R in shRNA1+2-transfected cells, supporting the conclusion that SNX14 accelerates endocytosis of 5-HT 6 R ( Fig. 4C-E) . The levels of SNX14 stayed relatively constant over time after 5-HT treatment even in the presence of phosphatase (Fig. 4F,G) .
SNX14 does not retain GAP activity but specifically binds and sequesters Gas, thus inhibiting 5-HT 6 R downstream signaling pathway SNX14 contains a putative RGS domain ( Fig. 1A ; supplementary material Fig. S1A ). Given that the closely related protein, SNX13 has been reported to act as a RGS for Gas (Zheng et al., 2001) , we evaluated whether SNX14 also acts as a RGS-GAP for Gas. We found that SNX14 bound to the activated form of Gas [activation was achieved by addition of aluminium magnesium fluoride (AMF), GTPcs or the Q227L mutation, each of which promotes conformational changes that resemble the transition state of Gas (Tesmer et al., 1997) ]. SNX14 did not bind to wildtype Gai1 or the active form of Gai1 (Q204L) even in the presence of AMF. The isolated RGS domain of SNX14 interacted with constitutively active Gas (Q227L) and with wild-type Gas but not with wild-type Gai1 or the active form of Gai1 (Q204L) (Fig. 5A ). SNX14 or activated Gas was, respectively, pulled down with GST-Gas or the GST-RGS domain from mouse brain Shown are negative film images of in situ hybridization of parasagittal sections from E16 (a) and E18 (b) embryos and coronal sections from P21 (c) and adult (d) rat brain. CTX, cortex; CA1, hippocampal CA1 area; INTES, intestine; OB, olfactory bulb; OE, olfactory epithelium; PIR, piriform cortex; SKM, skeletal muscle; SC, spinal cord. Scale bars: 6 mm in sagittal sectioned embryo; 3 mm in coronal sectioned brain. (C) Tissue distribution of SNX14 protein in .4-weekold C57BL/6 mice as assessed with an anti-SNX14 antibody. (D) Endogenous SNX14 is expressed in brain lineage cell lines. Cell lines: HT-22, mouse hippocampal; C6, rat glioma; L929, mouse fibrosarcoma; SK-N-SH, human neuroblastoma; HEK293T, human embryonic kidney; HeLa, human cervical cancer; COS-7, African green monkey kidney fibroblast. (E) SNX14 interacts with 5-HT 6 R. Mouse brain lysates were incubated at 4˚C for 2 h with purified GST or GSTiL3 of 5-HT 6 R bound to glutathione beads in a lysis buffer, separated by SDS-PAGE and silver-stained. The band indicated by the arrowhead was excised and analyzed by micro-LC-MS/MS. We performed micro-LC-MS/MS analysis twice and the listed proteins were identified in both trials. (F) HEK293T cells were co-transfected with 36HA-5-HT 6 R and EGFP, EGFP-SNX14, the EGFP-tagged RGS-PX domain of SNX14 (EGFP-RGSPX, amino acids 336-937), EGFP-SNX9 or EGFP-SNX18. Lysates were immunoprecipitated (IP) with anti-HA antibody and immunoblotted (IB) with anti-GFP antibody. The arrowheads indicate the size of EGFP-SNX14 (137 kDa) and EGFP-RGSPX (93 kDa). (G) HEK293T cells were transfected with EGFP-tagged iL2, iL3 and the C-terminal (CT) of 5-HT 6 R, lysed and pulled down with a purified SNX14 GST-tagged RGS domain (GST-RGS, 15 mg). Residual cell lysates (10% of total cell lysates; TCL) were subjected to SDS-PAGE and immunoblotted with anti-GFP antibody. The RGS domain of SNX14 specifically interacts with the iL3 domain of 5-HT 6 R. (H) HEK293T cells were transfected with GFP, GFP-iL3 and GFP-iL3 mutants (K262A, K265A or K262A/265A), lysed and pulled down with purified GST-RGS. The immunoprecipitated proteins were immunoblotted with anti-GFP antibody. (I) HEK293T cells were transfected with HA, 36HA-5-HT 6 R, HA-b 2 AR or HA-D 1 DR, lysed and pulled down with purified GST-RGS. The same amount of GST-RGS (shown in the Coomassie staining in G) was used in G, H and I for the pulldown assay.
lysates (Fig. 5B ). In addition, purified His-Gas (AMF-activated) interacted with the purified GST-RGS domain but not with GST-RGS4 (Fig. 5C ). Mutationally activated Gas (Q227L) also strongly bound to the purified GST-RGS domain but not to GST-RGS4 (Fig. 5C ), suggesting that there is a specific interaction between the RGS domain of SNX14 and Gas. We next investigated whether SNX14 could potentiate the GTPase activity of Gas. GTP single-turnover assays showed that SNX14 did not promote the GTPase activity of Gas (Fig. 5D ).
Given that SNX14 does not possess GAP activity for Gas, we queried the physiological meaning of the SNX14-Gas interaction by performing cAMP production assays. 5-HT increased cellular cAMP in control cells but not in cells expressing the RGS domain of SNX14. cAMP elevation in the presence of forskolin, which activates Gas in the absence of adenylyl cyclase, was equivalent in the presence or absence of SNX14 (Fig. 5E ). These results suggest that SNX14 acts as a negative regulator that inhibits Gasmediated cAMP production perhaps by binding and sequestering Gas. We found that endogenous SNX14 was located in endosome-like punctate structure, but upon addition of 5-HT, SNX14 translocated to the plasma membrane (supplementary material Fig. S2B ,C). TIRF imaging also showed that SNX14 appeared to be recruited to the plasma membrane by 5-HT treatment coincidently with Gas, and they disappeared together (supplementary material Fig. S2C ).
The iL3 region of 5-HT 6 R is known to directly bind to Gas (Kang et al., 2005) . Given that we found that the RGS of SNX14 also interacts with iL3 of 5-HT 6 R ( Fig. 1G ,H), we tested whether the RGS of SNX14 and Gas competitively bind to iL3 of 5-HT 6 R. The interaction between RGS of SNX14 and iL3 of 5-HT 6 R gradually decreased, with a concomitant increase in the interaction between Gas and iL3 of 5-HT 6 R upon increasing the amount of Gas protein in the reaction ( Fig. 6A-D) , suggesting that there is a competition between RGS of SNX14 and Gas in their binding to iL3 of 5-HT 6 R.
PKA-mediated phosphorylation of SNX14 re-routes SNX14 from Gas binding to 5-HT 6 R binding, facilitating the internalization of that receptor
We next tested whether SNX14 is phosphorylated by cAMPdependent PKA, a downstream effector of Gas-mediated signaling pathways. Indeed, SNX14 was phosphorylated at serine and threonine, but not tyrosine residues, upon forskolin treatment ( Fig. 7A-C) . We found that recombinant RGS was strongly phosphorylated in vitro by the catalytic subunit of PKA (PKAnes) (Fig. 7D ) and LC-MS/MS showed that the RGS domain was phosphorylated on S382 and S388 (supplementary material Fig.  S3 ). Although these serine residues are not canonical sites for PKA phosphorylation, PKA-mediated phosphorylation was markedly reduced in an S382A/S388A double mutant of RGS (supplementary material Fig. S3 ; Fig. 7D ). This was further confirmed in cells transfected with RGS or various S382/S388 mutants and PKAnes. The phosphorylation of RGS increased by PKAnes was substantially reduced in S382A/S388A single or double mutants (Fig. 7E) .
We next tested whether phosphorylation of SNX14 affects its binding to Gas. Firstly, when transfected with PKAnes, there was dramatic reduction in the interaction between the RGS-PX domain of SNX14 and Gas in the presence of AMF or a constitutively active Gas (Q227L) (Fig. 7F) . Secondly, the single or double phospho-mimetic mutants (S382D/S388D) of RGS either markedly reduced or completely abolished the binding between RGS and Gas (Fig. 7G) . These results suggest that the phosphorylation of RGS domain by PKA dramatically decreases its affinity for Gas.
We next tested whether phosphorylation affects the SNX14-induced endocytic trafficking of surface 5-HT 6 R. Interestingly, the S382A/S388A double phospho-deficient mutant did not promote endocytosis of 5-HT 6 R whereas the S382D/S388D double phospho-mimetic mutant had an effect on 5-HT 6 R levels similar to the RGS-PX domain (Fig. 8A,B) . These results suggest that PKA-mediated phosphorylation of SNX14 is required for its effect on internalization of 5-HT 6 R. We tested further this possibility using the PKA inhibitor, H-89. After H-89 treatment, co-expression of the RGS-PX domain did not decrease the initial levels of either total or surface levels of 5-HT 6 R ( Fig. 8C-F) . Given that we showed that phosphorylated the RGS-PX domain no longer binds Gas (Fig. 7F,G) , our results imply that phosphorylated SNX14 might be 're-routed' for preferential binding to 5-HT 6 R, thus enhancing endocytic internalization and degradation of that receptor.
DISCUSSION
In this study, we found that SNX14, as might be expected of a sorting nexin, accelerates internalization and degradation of 5-HT 6 R. We also found that SNX14 specifically binds and sequesters Gas, thus inhibiting downstream cAMP production. We, thus, provide strong evidence that SNX14 plays roles as an endogenous negative regulator of 5-HT 6 R trafficking and signaling.
Besides Gas, 5-HT 6 R is known to interact with various proteins such as Fyn tyrosine kinase (Yun et al., 2007) , Jun activation domain-binding protein-1 (Jab1, also known as COPS5) (Yun et al., 2010) , mammalian target of rapamycin (mTOR) (Meffre et al., 2012) , microtubule-associated protein 1B light chain (MAP1B-LC) (Kim et al., 2014) and cyclin-dependent kinase 5 (Cdk5) (Duhr et al., 2014) . The C-terminus of 5-HT 6 R interacts with the Fyn and activation of 5-HT 6 R stimulates (B-D) HEK293T cells were co-transfected with HA-5-HT6R or HA-b2AR and EGFP-C1 or EGFP-RGSPX. 48 h after transfection, the cells were starved for 16 h and treated with 10 mM 5-HT or 25 mM isoproterenol (Iso) for the times indicated. Surface biotinylation was performed and surface and total proteins were identified with anti-HA antibody. The levels of surface (C) and total (D) proteins were normalized to the level at 0 min of each receptor in the EGFP control and are presented as means6s.e.m. (n53). *, P,0.05 (ANOVA and Tukey's HSD post hoc test); ns, not significant. (E) Coordination of the RGS-PX domain expression and 5-HT 6 R loss. HEK293 cells expressing 5-HT 6 R were transiently or stably transfected with the RGS-PX domain using the Tet-On system. Cells were cultured with or without 1 mg/ml doxycycline (Dox). The intensity values of 5-HT 6 R at the indicated times were normalized to that at time zero and the intensity values of the RGS-PX domain at the times indicated were normalized to that at time 48 h to emphasize the internalization of surface 5-HT 6 R. The expression of the RGS-PX domain and the internalization of 5-HT 6 R are tightly correlated after Dox treatment. (F) Introduction of the RGS-PX domain reduces the levels of 5-HT 6 R. A 66His-tagged RGS-PX protein (66His-RGSPX) was purified as described in the Materials and Methods (see gel on the right). HEK293 cells stably expressing 5-HT 6 R were transfected purified 66His-RGSPX protein using the Chariot 2 system. Cells were incubated with Chariot complex for 2 h, then fixed and stained with Alexa-Fluor-594-conjugated anti-rat antibody for 36HA-5-HT 6 R and Alexa-Fluor-488-conjugated anti-mouse antibody for the 66His-RGSPX (left panel). Scale bars: 20 mm. The cells were lysed at the times indicated after protein delivery and immunoblotted with anti-HAantibody. Lower bar graph: the quantification from three independent experiments. Data are mean6s.e.m. *P,0.05, ***P,0.001 (ANOVA and Tukey's HSD post hoc test).
extracellular-regulated kinase 1/2 through the Fyn-dependent pathway (Yun et al., 2007) . 5-HT 6 R also interacts with mTORC1 and activates the phosphoinositide 3-kinase (PI3K), Akt and mTOR signaling pathway in prefrontal cortex, and recruitment of mTOR by 5-HT 6 R contributes to the perturbed cognition in schizophrenia (Meffre et al., 2012) . In addition, the C-terminus and iL3 of 5-HT 6 R selectively interact with the N-terminus and C-terminus of Jab1, respectively. Interestingly, hypoxia increases the expression level of 5-HT 6 R and Jab1, indicating that 5-HT 6 R and the Jab1 complex and its downstream signaling pathway protect the cells against hypoxia (Yun et al., 2010) . A recent study has further shown that direct recruitment of CDK5 and p35 (also known as CDK5R1) to the C-terminus of 5-HT 6 R leads to the phosphorylation of this region and promotes neurite outgrowth by activating Cdc42 (Duhr et al., 2014) . Such diverse 5-HT 6 R-mediated downstream signaling pathways and second messengers might explain why agonists and antagonists of 5-HT 6 R result in conflicting effects in different studies (Marazziti et al., 2011) .
There are many functional interactions between signaling and membrane trafficking (Ponimaskin et al., 2005; Renner et al., 2012) . The best example is b-arrestin, which binds to GPCRs and evokes their internalization through clathrin-coated pits but also functions to activate various signaling cascades (DeWire et al., 2007) . Likewise, SNX14 modulates G-protein signaling as well as GPCR trafficking, suggesting that SNX14 bilaterally modulates Gas-linked GPCRs signaling as a dual negative regulator. Although not examined in this study, Gas is known to traffic through lipid rafts and its sequestration attenuates Gas signaling (Allen et al., 2009 ). Participation of SNX14 in this process might add another level of regulation relevant to psychiatric disorders (Donati et al., 2008; Donati and Rasenick, 2003) .
Although we have not investigated a possible role of SNX14 on receptor insertion or recycling, we believe that the role of SNX14 resides in the endocytic realm for the following reasons. First, when we treated with dynasore to block the endocytosis, we found that the levels of 5-HT 6 R gradually increased even in the presence of SNX14 (supplementary material Fig. S4A ). This suggested that SNX14 does not affect the insertion of the receptor. Second, a lysosomal inhibitor, chloroquine also induced a gradual increase of 5-HT 6 R levels in the presence of SNX14 (supplementary material Fig. S4B ), suggesting that SNX14 does not affect the recycling of the receptor.
Regulators of Gas-linked GPCRs should have crucial roles in CNS, but specific RGS proteins for Gas in the brain have yet to be found. Although the RGS domain of SNX13 is reported to function as a specific GAP for Gas (Zheng et al., 2001 ), its expression is high in heart and skeletal muscles but virtually absent in brain. The RGS domain of axin is known to bind Gas, but it also interacts Ga 12 or Ga o , thus showing no specificity for Gas (Castellone et al., 2005) . SNX25 also contains an RGS domain and induces TGF-b receptor degradation or interacts with D 1 , D 2 dopamine receptors playing a role in trafficking. Our results show that SNX14 contains a RGS domain specific for Gas. Despite its inability to act as a RGS-GAP, we demonstrated that SNX14 successfully inhibits the production of cAMP, thus we proposed that although it is not a classical GAP for Gas, SNX14 acts as a negative regulator that inhibits Gas-mediated downstream signaling pathways by binding and sequestering Gas.
Regulation of RGS function by feedback phosphorylation is seen in other RGS or RGS-like proteins. Phosphorylation of RGS2 by protein kinase C (PKC) reduces its GAP activity (Cunningham et al., 2001 ) and ERK-mediated phosphorylation of RGS-GAIP increases its GAP activity (Ogier-Denis et al., 2000) . Through phosphorylation, signaling cascades can be fine-tuned in either a feedback or feed-forward manner. The binding affinity of SNX14 for Gas is dramatically decreased by PKA-mediated phosphorylation of its RGS domain; thereby relieving Gas inhibition by SNX14 and facilitating Gas activation of adenylyl Fig. 5 . SNX14 contains a non-functional RGS domain and specifically binds and sequesters Gas, thus inhibiting 5-HT 6 R-induced cAMP production. (A) HEK293T cells were co-transfected with an EGFP-tagged RGS domain of SNX14 (EGFP-RGS, amino acids 336-468) or EGFP-SNX14 and FLAG-tagged Gas (wild-type, WT), Gas with a Q227L mutation (QL, at residue 227), Gai1 (WT) or Gai1 with a Q204L mutation (QL, residue 204). 48 h after transfection, the cells were lysed and immunoprecipitated (IP) with anti-GFP antibody and immunoblotted (IB) with anti-FLAG antibody in the presence or absence of AMF, GDP or GTPcS. GFP lanes are shown separated due to different protein size. (B) Purified GST, GST-tagged Gas, Gai1, the RGS domain from SNX14 (GST-RGS) or RGS4 (10 mg) glutathione-agarose beads were incubated overnight at 4˚C in the presence or absence of AMF with 10 mg of mouse brain lysate containing 100 mM GDP. Right panel, Coomassie-stained SDS-PAGE gels loaded with purified GST and GST fusion proteins used in the pulldown assay. (C) GST, GST-RGS or GST-RGS4 on glutathione-agarose beads (5 mg) were incubated with purified His-Gas or His-Gas (QL) in the presence or absence of GDP and/or AMF. Samples were immunoblotted with anti-Gas antibody. Right panels, Coomassie-stained SDS-PAGE gels loaded with purified GST and GST fusion proteins used in the pulldown assay. (D) Quantitative detection of GAP activity of the SNX14 RGS domain and human RGS4 (hRGS4). Purified HisGas, GST-RGS of SNX14 and GST-hRGS4 were used for GTP hydrolysis assay. Gas (closed squares, 90 nM) was assayed with RGS (closed circle, 900 nM) or hRGS4 (closed triangle, 500 nM). Neither RGS nor hRGS4 increased the rate of GTP hydrolysis of Gas. (E) The RGS domain inhibits cAMP production induced by 5-HT treatment but not by forskolin (Fsk) treatment. HEK293T cells were co-transfected with 5-HT 6 R and EGFP or EGFP-RGS and production of cAMP was measured. The data are means6s.e.m. from three independent experiments. *P,0.05 (paired t-test).
cyclase and the subsequent cAMP signaling pathways. Thus, activation of the 5-HT 6 R-mediated cAMP-PKA pathway depends on the extent of SNX14 phosphorylation by PKA, suggesting that this might fine-tune 5-HT 6 R-mediated signaling in the brain which might contribute to the cellular responses observed in neurological and psychiatric disorders, suggesting SNX14 as a potential therapeutic target.
MATERIALS AND METHODS

DNA constructs
The full-length of mouse SNX14 was amplified by PCR from an Image cDNA clone (Invitrogen, Carlsbad, CA) and subcloned into pEGFP-C1 (Clontech, Palo Alto, CA) and pGEX-4T-1 (Amersham Biosciences, Arlington Hts, IL). The PXA-RGS-PX domain (amino acids 130-937), the RGS-PX domain (amino acids 336-937), the PXA domain (amino acids 130-304), the RGS domain (amino acids 336-468) and the PX domain (amino acids 558-937) of SNX14 were subcloned into EGFP or mCherry empty vector. 66His-RGSPX was cloned into pcDNA-3.1A (Invitrogen, San Diego, CA). HA-tagged b 2 AR, Gas (WT), Gas (Q227L), Gai1 (WT) and Gai1 (Q204L) were cloned into pCMV4-FLAG vector (Sigma, St. Louis, MO). HA-b 2 AR, HA-RGS4 and 36HA-5-HT 6 R were purchased from the Missouri S&T cDNA Resource Center (Rolla, MO). PM-GFP was constructed by subcloning of the GAP-43 membrane anchoring domain into pDisplay-EGFP vector (Invitrogen). The fidelity of all constructs was verified by DNA sequencing.
Antibodies
The anti-SNX14 antibody was raised against RAENTERKQNQNY (amino acids 759-771) and anti-human SNX14 polyclonal antibody was purchased from Sigma. Other antibodies used were: anti-GFP (EMD Millipore, Billerica, MA), anti-His (QIAGEN, Valencia, CA), anti-transferrin receptor, anti-EEA1 (BD Biosciences, San Jose, CA), anti-b-actin, antib-tubulin, anti-b-tubulin-III, anti-phosphoserine, anti-phosphothreonine, anti-phosphotyrosine (EMD Millipore), anti-FLAG, anti-GST (Sigma), anti-5-HT 6 R (H-143; Santa Cruz Biotechnology, Santa Cruz, CA), anti-rat HA (Roche, Basel, Switzerland), anti-mouse HA (COVANCE, Princeton, CA), anti-Gas (Santa Cruz Biotechnology) and secondary antibodies conjugated to Alexa Fluor 405, 488 or 594 (Invitrogen).
Protein-lipid overlay assay
Protein-lipid overlay assays were performed using PIP strips (Echelon Research Laboratories, Salt Lake City, UT). Membranes were blocked with 3% (w/v) BSA in Tris-buffered saline with 0.1% Tween 20 (TBS-T) for 1 h at room temperature. Membranes were incubated overnight at 4˚C in 3% BSA/TBS-T, together with 0.5 mg/ml of various purified GSTtagged proteins. Membranes were further incubated with anti-GST antibody for 1 h at room temperature, probed with horseradish peroxide (HRP)-conjugated anti-rabbit IgG antibody (Jackson ImmunoResearch, West Grove, PA) and visualized by enhanced chemiluminescence (GE Healthcare Bio-Sciences, Uppsala, Sweden).
Tissue preparation and immunohistochemistry
Experiments were performed in accordance with guidelines set forth by the Seoul National University Council Directive for the proper care and use of laboratory animals. Mice were perfused transcardially with heparinized PBS followed by ice-cold 4% paraformaldehyde in PBS. Brains were removed, immersed in the same fixative for 4 h, cryoprotected by infiltration with 10-30% sucrose solution, embedded in an Optimal Cutting Temperature compound and rapidly frozen in 2-methanol. Specimens were cut into 35-mm coronal sections on a cryostat and immunostained with anti-SNX14 antibody. Sections were treated with 1% FBS with 0.3% Triton X-100 in PBS for 30 min, blocked with 1% H 2 O 2 in PBS, rinsed with PBS, incubated with the primary antibody for overnight at Fig. 6 . The RGS domain of SNX14 and Gas competitively bind to iL3 of 5-HT 6 R. Purified GST-iL3 of 5-HT 6 R was incubated with cell lysates (500 mg) from cells overexpressing the EGFP-tagged RGS domain of SNX14 (EGFP-RGS) and the indicated amounts of purified His-Gas, and a GST pulldown assay was performed. The samples were immunoblotted with anti-GFP antibody, stripped and re-immunoblotted with anti-His antibody. Lower panels, Coomassie stains of 5 mg of GST-iL3, 2 mg of His-Gas and immunoblots (IB) with antiHis antibody and anti-GFP antibody using 15% of the total cells lysate (TCL) as inputs. (B) 500 mg cell lysates from cells overexpressing EGFP-iL3 was pulled down with a purified SNX14 RGS domain (GST-RGS) and the indicated amount of purified His-Gas. Samples were immunoblotted with anti-GFP antibody. The interaction between RGS and iL3 was substantially decreased with the increased amount of Gas. A Coomassie staining of purified GST (5 mg), GST-RGS (10 mg) and His-Gas (2 mg) is also shown. 15% of the TCL was loaded as inputs. (C,D) Quantification from three independent experiments as described in A and D, respectively. Data were normalized to the maximum intensity of each protein.
4˚C and exposed to the HRP-conjugated anti-rabbit IgG (Rockland Immunochemicals, Gilbertsville, PA) for 1 h at room temperature. Immunostaining was visualized by staining with diaminobenzidine (Vector, Burlingame, CA) for 3 to 5 min and viewing under a FSX100 microscope (Olympus, Tokyo, Japan).
Cyclic AMP enzyme immunoassay
HEK293T cells were transfected using Lipofectamine-2000 (Invitrogen) . At 48 h after transfection, the cells were starved for 16 h and treated with chemicals followed by 10 mM 5-HT for 20 min or 25 mM forskolin for 3 min. The cells were lysed and cAMP was measured with a cAMP direct immunoassay kit (Abcam, Cambridge, MA).
Single turnover GTPase assay BL21 bacterial cells were transformed with GST-RGS, GST-RGS mutants (S382D/S388D and S382A/S388A), 66His-Gas and 66His-Gai1. In the case of Gas, 90 nM protein was applied with 900 nM of either RGS or RGS mutants (S382D/S388D and S382A/S388A) or 500 nM human RGS proteins whereas 80 nM Gai1 protein was used for assay. G proteins were loaded with [ 32 P]GTP and GTPase assays were carried out as described previously except that the assay temperature was 4˚C (Berman et al., 1996) .
Immunoprecipitation and immunoblotting
HEK293T cells were co-transfected with 36HA-5-HT 6 R and various SNX14 mutants, lysed in a lysis buffer (20 mM Tris-HCl pH 8, 10% glycerol, 137 mM NaCl, 2 mM EDTA), and centrifuged for 20 min at 14,000 g at 4˚C. 500 mg total proteins from the supernatant were incubated with anti-GFP, anti-FLAG, anti-phosphoserine, antiphosphothreonine or anti-phosphotyrosine antibody overnight at 4˚C, incubated with 30 ml of protein-A-Sepharose for 1 h, pelleted by centrifugation and analyzed by SDS-PAGE. Proteins on the gels were transferred onto PVDF membranes (Pall Life Sciences, Ann Arbor, MI) and incubated with primary antibodies for 1 h at room temperature. The 
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TIRF microscopy
Cells were imaged using an Olympus IX-71 microscope fitted with a 606, 1.45 NA TIRF-lens and controlled by Cell M software (Olympus). 488 and 561 nm diode lasers were coupled to the TIRF microscopy condenser through two independent optical fibers. Using software, we changed the angle of the incident laser to get the calculated penetration depth of ,120 nm. Cells were typically imaged either in single channel or in two channels by sequential excitation with 0.1-s exposures and detected with a Andor iXon 897 EMCCD camera (5126512; Andor Technologies, Belfast, Northern Ireland). The Image J program (National Institutes of Health) was used for analysis.
PKA kinase assay
GST-RGS of SNX14 (0.5 mg/ml) was incubated with 1000 units/ml catalytic subunit of PKA (New England Biolabs, Ipswich, MA) at 30˚C for 2 h in 50 mM Tris-HCl pH 7.5, 10 mM MgCl 2 and 200 mM ATP. For the autoradiography, the reaction mixture was supplemented with clabeled ATP to a final specific activity of 200 mCi/mmol. RGS phosphorylation was assayed in the presence of reducing agents.
Surface biotinylation and membrane protein extraction 36HA-5-HT 6 R stable cells were transfected with various SNX14 mutants. 48 h after transfection, cells were starved for 16 h in serumfree media and treated with 10 mM 5-HT for the times indicated. The cells were washed with ice-cold PBS, incubated with 0.25 mg/ml EZLinkH Sulfo-NHS-SS-Biotin in PBS for 30 min at 4˚C, rinsed in Quenching Solution with TBS to remove free biotin reagents, and lysed. After centrifugation, the supernatants were incubated with 50 ml of 50% slurry of immobilized NeutraAvidin for 2 h at 4˚C. To detect internalized 5-HT 6 R (Fig. 3D,E) , 36HA-5-HT 6 R stable cells were transfected with various SNX14 mutants. After starvation, surface proteins were biotinylated with 0.25 mg/ml EZ-LinkH Sulfo-NHS-SSBiotin in PBS for 30 min at 4˚C. Unreacted biotin was removed by 50 mM glycine in PBS for 10 min at 4˚C and washed with cold PBS. The cells were treated with 10 mM 5-HT for indicated times and washed with cold PBS. Non-endocytosed biotin was cleaved in 50 mM glutathione, 75 mM NaCl and 75 mM NaOH in FBS solution for 20 min at 4˚C. After blocking and washing, cells were lysed and immunoprecipitated with NeutraAvidin for 2 h at 4˚C. Biotinylated proteins were eluted in SDS sample buffer followed by immunoblotting with an anti-HA antibody.
In-gel digestion and MS sample preparation
Immunoprecipitated protein samples were separated by one-dimensional SDS-PAGE and protein bands of interest were excised from the gel for an in-gel digestion procedure. Tryptic digest peptides obtained from the ingel digestion procedure were dissolved in 0.1% formic acid and 5% acetonitrile solution for mass spectrometry analysis.
Dephosphorylation by alkaline phosphatase treatment
Tryptic digest peptide samples obtained from the in-gel digestion procedure were also resuspended in 16NEBuffer-3 and alkaline phosphatase solution (10 unit/ml) was added to remove phosphate moieties. After incubation for 2 h at 37˚C, the dephosphorylation was stopped by adding formic acid solution to a final concentration of 5%.
Micro-LC-MS/MS analysis
In-gel digested peptide samples and alkaline phosphatase-treated peptide samples were subjected to micro-LC-MS/MS experiments using an LTQ ion trap mass spectrometer (ThermoElectron, San Jose, CA). Details of the micro LC-MS/MS analysis and protein database search process are as or phospho-mimetic (S382D, S388D) mutants and PKAnes (PKA catalytic subunit). The cells were lysed and immunoprecipitated with anti-GFP antibody, immunoblotted with anti-phosphoserine antibody. P-RGS, phosphorylated RGS. (F) Cells were co-transfected with EGFP, the EGFPtagged RGS-PX domain of SNX14 (EGFP-RGSPX) and/or FLAG-Gas (WT), FLAG-Gas QL (Q227L) and PKAnes. After 48 h transfection, the cells were treated with or without AMF, lysed, immunoprecipitated with anti-GFP antibody and immunoblotted with anti-FLAG antibody. The interaction between Gas (WT or Q227L) and SNX14 was diminished by PKAnes. Net intensity of immunoblotted Gas (WT or Q227L) was normalized to the value of Gas (WT or Q227L) in the absence of PKAnes. Data are the mean6s.e.m. (n55). **P,0.01; ***P,0.001 (paired t-test). (G) Phosphorylation of the RGS domain blocks Gas association and RGS phospho-mimetics also fail to bind Gas. HEK293T cells were cotransfected with FLAG-tagged Gas (WT) or Gas (Q227L) and the EGFP-tagged RGS domain of SNX14 (EGFP-RGS), various phospho-deficient or phospho-mimetic RGS domain mutants and PKAnes in the presence or absence of AMF. The cells were lysed, immunoprecipitated with anti-GFP antibody followed by immunoblotting with anti-FLAG antibody. Phosphorylation of RGS proteins by co-transfection of PKAnes inhibits the interaction between the RGS and Gas WT or Gas Q227L (first four lanes). Phospho-mimetic mutants lost the ability to interact with Gas, even in the presence of AMF (last six lanes).
described elsewhere (Choi et al., 2011) . Briefly, peptides were separated by C18 reversed phase capillary column and Agilent HP1100 quaternary LC pump. Solvent A (3% HCOOH, 5% CH 3 CN and 92% H 2 O) and Solvent B (3% HCOOH, 5% CH 3 CN and 92% H 2 O) were used to make a 120-min gradient. MS/MS spectra obtained in the micro-LC-MS/MS analysis were searched against an in-house protein database containing both SNX14 and EGFP using Bioworks Ver.3.2 and Sequest Cluster System. The differential modification search options for phosphorylation modification (+80 on Ser, Thr, Tyr) and oxidation (+16 on Met) were considered in the search and the maximum number of modifications that were allowed per peptide was seven. Manual assignments of fragment ions in each MS/MS spectrum were performed to confirm the database search results.
RNA interference
The small hairpin RNAs (shRNAs) from three nucleotides 42-52 (shRNA-1), 183-189 (shRNA-2), and 536-542 (shRNA-3) of the mouse SNX14 cDNA sequence (NM_172926) were designed. A pair of complementary oligonucleotides was synthesized separately with the addition of an ApaI site at the 59-end and an EcoRI site at the 39-end. The forward primer sequences were 59-CAGGTATCTGCATGTCTTATT-CAAGAGATAAGACATGCAGATACCTGTTTT-39, 59-GGTGGATA- Fig. 8 . Phosphorylation of SNX14 affects the SNX14-induced internalization of surface 5-HT 6 R. (A,B) Phosphorylation of SNX14 is required for the initial reduction of 5-HT 6 R. HEK293T cells were co-transfected with HA-5-HT 6 R and EGFP-C1 (control), the EGFP-tagged RGS-PX domain of SNX14 (EGFP-RGSPX), and EGFP-phospho-deficient (S382A/S388A) or EGFP-phospho-mimetic RGS-PX domain mutants (S382D/S388D). The cells were starved for 5.5 h and incubated with 10 mM 5-HT for the times indicated, then surface biotinylation was performed. All of the quantitation assays were carried out in triplicate and the results were normalized to the levels of EGFP group at time 0. Lower graphs, the quantification from three independent experiments. Asterisks indicate significant changes between the RGS-PX domain group and EGFP group and between the S382A/S388A group and the RGS-PX domain group at matching time points. *P,0.05 (ANOVA and Tukey's HSD post hoc test). (C) Experimental scheme of PKA inhibitor (H-89) treatment. HEK293 cells stably expressing 5-HT 6 R were transfected with EGFP-C1 or EGFP-RGSPX. 10 mM H-89 was added into culture medium as indicated in the scheme. The total and surface proteins were extracted 30 h after transfection. (D) Immunoblotting was performed with anti-HA and anti-b-tubulin antibodies after treatment as described in C. SNX14 affects neither the initial levels of total nor that of surface 5-HT 6 R. (E,F) Quantification of surface (E) or total (F) 5-HT 6 R levels after 5-HT treatment in the presence or absence of H-89. The surface or total levels of 5-HT 6 R was normalized to that at time 0 after 5-HT treatment.
TTCCATCTATTTTCAAGAGAAATAGATGGAATATCCACCTTTT-39 and 59-GAGGATGACTCTCCAGTAGTTCAAGAGACTACTGGA-GAGTCATCCTCTTTT-39 (the underlined letters are the SNX14-siRNA sequences). The annealed cDNA fragment was cloned into the ApaIEcoRI sites of pSilencer-1.0-U6-mRFP vector (Ambion, Austin, TX). The knockdown efficiency was tested in the HT-22 cells and EGFP-SNX14-transfected HEK293T cells.
Protein delivery
The cloned 66His-RGSPX in pET-23b vector (EMD Millipore) was transformed into BL-21 and cultured in 26YT medium supplemented with ampicillin. After overnight induction with 0.5 mM IPTG at 30˚C, cells were sonicated in the lysis buffer (50 mM NaH 2 PO 4 pH 8.0, 300 mM NaCl, 5 mM Decyl-b-D-Maltopyranoside (Anatrace, Maumee, OH) and centrifuged for 60 min at 13,000 g. The supernatants were incubated with Ni-NTA agarose (Qiagen) at 4˚C for 30 min. The beads were then washed extensively with lysis buffer and the protein was eluted with an elution buffer (50 mM NaH 2 PO 4 pH 8.0, 200 mM NaCl, 200 mM imidazole). To further purify 66His-RGSPX, whole proteins were filtered with an Ultracel-30K centrifugal filter (Millipore, Billerica, MA) at 5000 g for 10 min and the supernatant was immediately applied to a Superdex 200 10/300 GL column (GE Healthcare) at a flow rate of 0.5 ml/min at 4˚C. Proteins were collected by a FPLC-NGC chromatography system. The purified 66His-RGSPX protein was introduced to 5-HT 6 R stable HEK293 cells using Chariot (Active Motif, Carlsbad, CA). Briefly, 4 ml of Chariot was diluted in 40 ml of 80% DMSO, mixed with 40 ml of PBS containing purified the RGS-PX domain (1.25 mg) and followed by 30 min incubation at room temperature. The complex was diluted in serum-free DMEM to a volume of 200 ml and added to 5-HT 6 R stable cells. The cells were incubated with the complexes in serum-free medium for 1 h, followed by 1 ml serum-containing medium for 2 h.
